REKAMBYS 900 mg, suspension for injection with extended release bottle, 3 ml
Active ingredients: Rilpivirine
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for injection with extended releasebottle, 3 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- REKAMBYS 900 mg, suspension injectable à libération prolongée
- Pharmaceutical form
- suspension injectable à libération prolongée
- Route of administration
- intramusculaire
- Presentation description
- 1 flacon(s) en verre de 3 ml avec seringue(s) avec adaptateur(s) pour flacon avec aiguille(s)
- Marketing authorisation holder
- JANSSEN CILAG INTERNATIONAL NV
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jul 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
60150638CIP73021987CIP133400930219874Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RILPIVIRINEsuspension | 900 mg · un flacon de 3 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.